300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
InsurTech
Platforms
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
eSports
Facebook
Renewable Energy
Software
Blockchain
Theatre
Beauty
Fashion
Medical
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Web3
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Recruiting
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Sudan
Malawi
Isle of Man
Iran
Madagascar
Haiti
Russian Federation
Lesotho
Nepal
Pakistan
Turkey
Mexico
Tajikistan
Liberia
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Moldova
Seychelles
Botswana
South Africa
Paraguay
France
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Senegal
Portugal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Barbados
Belgium
Austria
Cyprus
Ethiopia
Qatar
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bolivia
Bahrain
Belize
Algeria
Jersey
Estonia
Belarus
Hungary
Finland
Grenada
Israel
Italy
Honduras
Lithuania
Liechtenstein
Cambodia
Iceland
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Inveni Capital, VC Fund

Inveni Capital

VC Fund

Helsinki, Finland

Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Inveni Capital invests in

MedicalHealth CareBiotechnologyMedical DeviceInformation Technology

Stages Inveni Capital invests in

Venture - Series Unknown

Countries Inveni Capital invests in

FinlandUnited Kingdom

Round sizes

Venture - Series Unknown $3.4M–$11M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Venture - Series Unknown
$3.4M–$11M

Investment Focus

Industry

  • Medical 1 (50%)
  • Health Care 1 (50%)
  • Biotechnology 1 (50%)
  • Medical Device 1 (50%)
  • Information Technology 1 (50%)

Country

  • Finland 1 (50%)
  • United Kingdom 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Aki Prihti
Aki Prihti Partner
Partner Total investments: 0 Find email
Partner Total investments: 0 Find email
Wolfgang Pieken
Wolfgang Pieken Partner
Partner Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain. $10.7M / Venture - Series Unknown / Apr 14, 2015
BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures. $3.4M / Venture - Series Unknown / Jun 11, 2014

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
InsurTech
Platforms
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
eSports
Facebook
Renewable Energy
Software
Blockchain
Theatre
Beauty
Fashion
Medical
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Web3
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Recruiting
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Sudan
Malawi
Isle of Man
Iran
Madagascar
Haiti
Russian Federation
Lesotho
Nepal
Pakistan
Turkey
Mexico
Tajikistan
Liberia
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
New Zealand
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Moldova
Seychelles
Botswana
South Africa
Paraguay
France
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Senegal
Portugal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Barbados
Belgium
Austria
Cyprus
Ethiopia
Qatar
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bolivia
Bahrain
Belize
Algeria
Jersey
Estonia
Belarus
Hungary
Finland
Grenada
Israel
Italy
Honduras
Lithuania
Liechtenstein
Cambodia
Iceland
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Inveni Capital invest in?

Inveni Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Inveni Capital invest in?

Inveni Capital typically joins rounds of $3.4M–$11M at Venture - Series Unknown. These are whole funding-round sizes, not Inveni Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Inveni Capital took part in.

How do I contact Inveni Capital?

Public channels for Inveni Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Inveni Capital?

The team at Inveni Capital includes Aki Prihti (Partner), Markku Fagerlund (Partner) and Wolfgang Pieken (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Inveni Capital Inveni Capital Find emails